1. Home
  2. CPIX vs OKYO Comparison

CPIX vs OKYO Comparison

Compare CPIX & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$3.08

Market Cap

73.6M

Sector

Health Care

ML Signal

N/A

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

N/A

Current Price

$1.71

Market Cap

85.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPIX
OKYO
Founded
1999
2007
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.6M
85.3M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
CPIX
OKYO
Price
$3.08
$1.71
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
137.3K
340.0K
Earning Date
06-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
58.70
N/A
EPS
N/A
N/A
Revenue
$42,010,949.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.75
N/A
52 Week Low
$1.85
$1.03
52 Week High
$6.27
$3.35

Technical Indicators

Market Signals
Indicator
CPIX
OKYO
Relative Strength Index (RSI) 33.13 41.97
Support Level $2.78 $1.52
Resistance Level $3.80 $2.25
Average True Range (ATR) 0.31 0.12
MACD -0.13 0.01
Stochastic Oscillator 3.00 48.48

Price Performance

Historical Comparison
CPIX
OKYO

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: